Kyma Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Kyma Therapeutics General Information
Description
Developer of antibodies intended to serve the healthcare industry. The company is engaged in the development of immune-modulating antibodies for novel targets in cancer and autoimmune diseases.
Contact Information
Corporate Office
- 44 Hartwell Avenue
- Lexington, MA 02421
- United States
Corporate Office
- 44 Hartwell Avenue
- Lexington, MA 02421
- United States
Kyma Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kyma Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kyma Therapeutics FAQs
-
When was Kyma Therapeutics founded?
Kyma Therapeutics was founded in 2021.
-
Where is Kyma Therapeutics headquartered?
Kyma Therapeutics is headquartered in Lexington, MA.
-
What industry is Kyma Therapeutics in?
Kyma Therapeutics’s primary industry is Drug Discovery.
-
Is Kyma Therapeutics a private or public company?
Kyma Therapeutics is a Private company.
-
What is Kyma Therapeutics’s current revenue?
The current revenue for Kyma Therapeutics is .
-
Who are Kyma Therapeutics’s investors?
Alloy Therapeutics and Pyxis Oncology have invested in Kyma Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process